Crossroads in the combined-modality management of gastroesophageal junction carcinomas.

Abstract

An epidemiologic shift in esophageal and gastric carcinomas has occurred in recent years in the Western world. Adenocarcinoma of the distal esophagus and gastroesophageal junction (GEJ) is now the predominant esophageal carcinoma, and proximal gastric cancers now account for nearly half of gastric carcinomas. Tumors involving the GEJ appear to be a distinct… (More)

Topics

Cite this paper

@article{Apisarnthanarax2008CrossroadsIT, title={Crossroads in the combined-modality management of gastroesophageal junction carcinomas.}, author={Smith Apisarnthanarax and Joel Tepper}, journal={Gastrointestinal cancer research : GCR}, year={2008}, volume={2 5}, pages={235-43} }